+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Eye Health Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 250 Pages
  • August 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5990520
The eye health products market is experiencing significant growth, driven by various factors including increasing awareness about eye health and the rising prevalence of eye-related disorders.The market is projected to reach $2.53 billion in 2024 and $4.26 billion by 2031, with a compound annual growth rate (CAGR) of 6.50%. As a vital part of the global eye care industry, eye health products are becoming more essential, particularly for the aging population.

Sales Analysis and Market Dynamics

The market has witnessed a steady increase in demand over the past years, driven by major and regional manufacturers and government bodies' efforts to raise awareness about eye health. These initiatives are particularly important due to the growing aging population and the associated rise in eye-related disorders. Public bodies are also encouraging the use of nutritional supplements and products as preventive measures to maintain eye health and reduce treatment costs.

Market Growth Drivers

The market's growth is propelled by several key factors:

1. Rising Prevalence of Eye Disorders: The increasing incidence of eye problems, especially among the elderly, is a major driver. Age-related issues such as macular degeneration, retinopathy, cataracts, infections, diabetes mellitus, optic neuritis, trachoma, and dry eye syndrome necessitate the use of appropriate treatments and precautionary measures, including nutritional supplements.

2. Impact of Digital Devices: The growing use of digital devices and prolonged screen time have led to a rise in myopia and digital eye fatigue. This trend is particularly notable among millennials, who are increasingly turning to eye health products to mitigate these issues.

Focus on Innovative Products

Companies are actively developing new eye health supplements with innovative ingredients to stand out in the market. Key ingredients currently dominate the market, but there is a growing interest in other beneficial substances such as astaxanthin, blueberries, omega-3 long chain PUFAs, DHA, and genistein. These innovations are often supported by clinical studies to verify their effectiveness.

Distribution Channels and Marketing Strategies

To reach a broader consumer base, manufacturers are leveraging various distribution channels, including super/hypermarkets, pharmacies, retail stores, and increasingly, e-commerce platforms. Online sales have surged due to the convenience they offer, and this trend is expected to continue. Companies are also partnering with major retailers to enhance product accessibility.

The rise in health consciousness among consumers, driven by lifestyle changes and increased screen usage, is further fueled by information available through social media, the internet, TV advertisements, and articles. These sources provide comprehensive details on eye care products, helping consumers make informed purchases. Companies are aligning their product offerings with consumer interests to capture a larger market share.

Regulatory Challenges and Product Recalls

The market faces challenges due to stringent regulations surrounding manufacturing, product safety, and efficacy claims. Regulations vary across regions, with some not permitting any health benefit claims. Manufacturers must navigate these regulatory Analysiss carefully to avoid penalties.

Product recalls due to regulatory issues can significantly impact market growth. For instance, regulatory checks and subsequent warnings from authorities can lead to product recalls, as seen with the FDA's actions against certain manufacturers. Such incidents highlight the importance of adhering to good manufacturing practices and maintaining product quality.

Country-wise Insights

United States

The U.S. holds a significant share of the market, driven by the high prevalence of chronic eye disorders and the widespread availability of commercial eye health products. The presence of major players in the market also contributes to its dominance.

Germany

Germany is a key market in Europe, benefiting from strong R&D activities, a rapidly developing insurance sector, and increasing demand for effective eye health products. Efforts to create robust supply chains and distribution channels further support market growth.

China

China's market is expanding due to the presence of numerous local players offering affordable eye health supplements, an expanding contract-manufacturing hub, and growing consumer awareness of eye health. The large patient pool with eye disorders also drives demand.

Category-wise Insights

Ingredients

Lutein and zeaxanthin are the most widely adopted ingredients in eye health products, primarily due to their effectiveness in treating a variety of eye disorders. Public awareness and clinical recommendations further boost their popularity.

Indications

Age-related macular degeneration (AMD) is the leading indication for eye health products, significantly contributing to market growth. The increasing prevalence of AMD globally, particularly in high-income countries with aging populations, underscores the need for effective treatment options.

Form

Capsules are the most popular form of eye health supplements, preferred for their wide availability, affordability, and longer shelf life compared to other formulations. Their acceptance among patients of all age groups also supports their market dominance.

Competitive Analysis

Major players in the eye health products market are actively acquiring local and small manufacturing companies to expand their market share. Advertisement strategies and online campaigns are key tools used by manufacturers to promote their products.

Key Developments

  • Approval of LUMIFY® Redness Reliever Eye Drops by Health Canada.
  • Introduction of PreserVision AREDS 2 Formula mini gel eye vitamins in the U.S. by Bausch and Lomb Incorporated.

Key Companies Profile

The market features several prominent companies, including The Nature's Bounty Co., Pfizer Inc., Amway International, Bausch + Lomb, Nutrivein, ZeaVision LLC, Kemin Industries, Inc., EyeScience, Nutrachamps, Bausch Health Companies Inc., and Vitabiotics Ltd.

Key Segments Covered

Ingredient

  • Lutein and Zeaxanthin
  • Antioxidants
  • Omega-3 Fatty Acids
  • Coenzyme Q10
  • Flavonoids
  • Astaxanthin
  • Alpha-Lipoic Acid
  • Other Ingredients

Indication

  • Age-related Macular Degeneration (AMD)
  • Cataract
  • Dry Eye Syndrome
  • Other Indications

Form

  • Tablet
  • Capsule
  • Others

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Eye Health Products Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Eye Health Products Market Outlook, 2019-2031
3.1. Global Eye Health Products Market Outlook, by Ingredient, Value (US$ Bn), 2019-2031
3.1.1. Key Highlights
3.1.1.1. Lutein and Zeaxanthin
3.1.1.2. Antioxidants
3.1.1.3. Omega-3 Fatty Acids
3.1.1.4. Coenzyme Q10
3.1.1.5. Flavonoids
3.1.1.6. Astaxanthin
3.1.1.7. Alpha-Lipoic Acid
3.1.1.8. Other Ingredients
3.2. Global Eye Health Products Market Outlook, by Indication, Value (US$ Bn), 2019-2031
3.2.1. Key Highlights
3.2.1.1. Age-related Macular Degeneration (AMD)
3.2.1.2. Cataract
3.2.1.3. Dry Eye Syndrome
3.2.1.4. Other Indications
3.3. Global Eye Health Products Market Outlook, by Form, Value (US$ Bn), 2019-2031
3.3.1. Key Highlights
3.3.1.1. Tablet
3.3.1.2. Capsule
3.3.1.3. Others
3.4. Global Eye Health Products Market Outlook, by Region, Value (US$ Bn), 2019-2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa
4. North America Eye Health Products Market Outlook, 2019-2031
4.1. North America Eye Health Products Market Outlook, by Ingredient, Value (US$ Bn), 2019-2031
4.1.1. Key Highlights
4.1.1.1. Lutein and Zeaxanthin
4.1.1.2. Antioxidants
4.1.1.3. Omega-3 Fatty Acids
4.1.1.4. Coenzyme Q10
4.1.1.5. Flavonoids
4.1.1.6. Astaxanthin
4.1.1.7. Alpha-Lipoic Acid
4.1.1.8. Other Ingredients
4.2. North America Eye Health Products Market Outlook, by Indication, Value (US$ Bn), 2019-2031
4.2.1. Key Highlights
4.2.1.1. Age-related Macular Degeneration (AMD)
4.2.1.2. Cataract
4.2.1.3. Dry Eye Syndrome
4.2.1.4. Other Indications
4.3. North America Eye Health Products Market Outlook, by Form, Value (US$ Bn), 2019-2031
4.3.1. Key Highlights
4.3.1.1. Tablet
4.3.1.2. Capsule
4.3.1.3. Others
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Eye Health Products Market Outlook, by Country, Value (US$ Bn), 2019-2031
4.4.1. Key Highlights
4.4.1.1. U.S. Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
4.4.1.2. U.S. Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
4.4.1.3. U.S. Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
4.4.1.4. Canada Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
4.4.1.5. Canada Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
4.4.1.6. Canada Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
4.4.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Eye Health Products Market Outlook, 2019-2031
5.1. Europe Eye Health Products Market Outlook, by Ingredient, Value (US$ Bn), 2019-2031
5.1.1. Key Highlights
5.1.1.1. Lutein and Zeaxanthin
5.1.1.2. Antioxidants
5.1.1.3. Omega-3 Fatty Acids
5.1.1.4. Coenzyme Q10
5.1.1.5. Flavonoids
5.1.1.6. Astaxanthin
5.1.1.7. Alpha-Lipoic Acid
5.1.1.8. Other Ingredients
5.2. Europe Eye Health Products Market Outlook, by Indication, Value (US$ Bn), 2019-2031
5.2.1. Key Highlights
5.2.1.1. Age-related Macular Degeneration (AMD)
5.2.1.2. Cataract
5.2.1.3. Dry Eye Syndrome
5.2.1.4. Other Indications
5.3. Europe Eye Health Products Market Outlook, by Form, Value (US$ Bn), 2019-2031
5.3.1. Key Highlights
5.3.1.1. Tablet
5.3.1.2. Capsule
5.3.1.3. Others
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Eye Health Products Market Outlook, by Country, Value (US$ Bn), 2019-2031
5.4.1. Key Highlights
5.4.1.1. Germany Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.2. Germany Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.3. Germany Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.1.4. U.K. Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.5. U.K. Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.6. U.K. Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.1.7. France Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.8. France Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.9. France Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.1.10. Italy Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.11. Italy Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.12. Italy Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.1.13. Turkey Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.14. Turkey Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.15. Turkey Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.1.16. Russia Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.17. Russia Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.18. Russia Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.1.19. Rest of Europe Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
5.4.1.20. Rest of Europe Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
5.4.1.21. Rest of Europe Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
5.4.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Eye Health Products Market Outlook, 2019-2031
6.1. Asia Pacific Eye Health Products Market Outlook, by Ingredient, Value (US$ Bn), 2019-2031
6.1.1. Key Highlights
6.1.1.1. Lutein and Zeaxanthin
6.1.1.2. Antioxidants
6.1.1.3. Omega-3 Fatty Acids
6.1.1.4. Coenzyme Q10
6.1.1.5. Flavonoids
6.1.1.6. Astaxanthin
6.1.1.7. Alpha-Lipoic Acid
6.1.1.8. Other Ingredients
6.2. Asia Pacific Eye Health Products Market Outlook, by Indication, Value (US$ Bn), 2019-2031
6.2.1. Key Highlights
6.2.1.1. Age-related Macular Degeneration (AMD)
6.2.1.2. Cataract
6.2.1.3. Dry Eye Syndrome
6.2.1.4. Other Indications
6.3. Asia Pacific Eye Health Products Market Outlook, by Form, Value (US$ Bn), 2019-2031
6.3.1. Key Highlights
6.3.1.1. Tablet
6.3.1.2. Capsule
6.3.1.3. Others
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Eye Health Products Market Outlook, by Country, Value (US$ Bn), 2019-2031
6.4.1. Key Highlights
6.4.1.1. China Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
6.4.1.2. China Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
6.4.1.3. China Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
6.4.1.4. Japan Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
6.4.1.5. Japan Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
6.4.1.6. Japan Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
6.4.1.7. South Korea Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
6.4.1.8. South Korea Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
6.4.1.9. South Korea Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
6.4.1.10. India Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
6.4.1.11. India Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
6.4.1.12. India Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
6.4.1.13. Southeast Asia Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
6.4.1.14. Southeast Asia Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
6.4.1.15. Southeast Asia Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
6.4.1.16. Rest of Asia Pacific Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
6.4.1.17. Rest of Asia Pacific Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
6.4.1.18. Rest of Asia Pacific Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
6.4.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Eye Health Products Market Outlook, 2019-2031
7.1. Latin America Eye Health Products Market Outlook, by Ingredient, Value (US$ Bn), 2019-2031
7.1.1. Key Highlights
7.1.1.1. Lutein and Zeaxanthin
7.1.1.2. Antioxidants
7.1.1.3. Omega-3 Fatty Acids
7.1.1.4. Coenzyme Q10
7.1.1.5. Flavonoids
7.1.1.6. Astaxanthin
7.1.1.7. Alpha-Lipoic Acid
7.1.1.8. Other Ingredients
7.2. Latin America Eye Health Products Market Outlook, by Indication, Value (US$ Bn), 2019-2031
7.2.1. Key Highlights
7.2.1.1. Age-related Macular Degeneration (AMD)
7.2.1.2. Cataract
7.2.1.3. Dry Eye Syndrome
7.2.1.4. Other Indications
7.3. Latin America Eye Health Products Market Outlook, by Form, Value (US$ Bn), 2019-2031
7.3.1. Key Highlights
7.3.1.1. Tablet
7.3.1.2. Capsule
7.3.1.3. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Eye Health Products Market Outlook, by Country, Value (US$ Bn), 2019-2031
7.4.1. Key Highlights
7.4.1.1. Brazil Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
7.4.1.2. Brazil Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
7.4.1.3. Brazil Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
7.4.1.4. Mexico Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
7.4.1.5. Mexico Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
7.4.1.6. Mexico Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
7.4.1.7. Argentina Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
7.4.1.8. Argentina Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
7.4.1.9. Argentina Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
7.4.1.10. Rest of Latin America Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
7.4.1.11. Rest of Latin America Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
7.4.1.12. Rest of Latin America Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
7.4.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Eye Health Products Market Outlook, 2019-2031
8.1. Middle East & Africa Eye Health Products Market Outlook, by Ingredient, Value (US$ Bn), 2019-2031
8.1.1. Key Highlights
8.1.1.1. Lutein and Zeaxanthin
8.1.1.2. Antioxidants
8.1.1.3. Omega-3 Fatty Acids
8.1.1.4. Coenzyme Q10
8.1.1.5. Flavonoids
8.1.1.6. Astaxanthin
8.1.1.7. Alpha-Lipoic Acid
8.1.1.8. Other Ingredients
8.2. Middle East & Africa Eye Health Products Market Outlook, by Indication, Value (US$ Bn), 2019-2031
8.2.1. Key Highlights
8.2.1.1. Age-related Macular Degeneration (AMD)
8.2.1.2. Cataract
8.2.1.3. Dry Eye Syndrome
8.2.1.4. Other Indications
8.3. Middle East & Africa Eye Health Products Market Outlook, by Form, Value (US$ Bn), 2019-2031
8.3.1. Key Highlights
8.3.1.1. Tablet
8.3.1.2. Capsule
8.3.1.3. Others
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Eye Health Products Market Outlook, by Country, Value (US$ Bn), 2019-2031
8.4.1. Key Highlights
8.4.1.1. GCC Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
8.4.1.2. GCC Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
8.4.1.3. GCC Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
8.4.1.4. South Africa Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
8.4.1.5. South Africa Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
8.4.1.6. South Africa Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
8.4.1.7. Egypt Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
8.4.1.8. Egypt Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
8.4.1.9. Egypt Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
8.4.1.10. Nigeria Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
8.4.1.11. Nigeria Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
8.4.1.12. Nigeria Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
8.4.1.13. Rest of Middle East & Africa Eye Health Products Market by Ingredient, Value (US$ Bn), 2019-2031
8.4.1.14. Rest of Middle East & Africa Eye Health Products Market by Indication, Value (US$ Bn), 2019-2031
8.4.1.15. Rest of Middle East & Africa Eye Health Products Market by Form, Value (US$ Bn), 2019-2031
8.4.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Indication vs By Form Heat map
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Pfizer Inc.
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. The Nature's Bounty Co.
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Amway International
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Bausch + Lomb
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Nutrivein
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. ZeaVision LLC
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Kemin Industries, Inc.
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. EyeScience
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Nutrachamps
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Bausch Health Companies Inc.
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Vitabiotics Ltd.
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Pfizer Inc.
  • The Nature's Bounty Co.
  • Amway International
  • Bausch + Lomb
  • Nutrivein
  • ZeaVision LLC
  • Kemin Industries, Inc.
  • EyeScience
  • Nutrachamps
  • Bausch Health Companies Inc.
  • Vitabiotics Ltd.

Methodology

Loading
LOADING...